Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6237 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
77-33        ONTOZRY Angelini Pharma S.p.A Original drug not imported to China Approved in EU The 77th Batch of Reference Listed Drugs
77-34        Atacand ANI Pharmaceuticals, Inc. Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-35        Atacand ANI Pharmaceuticals, Inc. Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-36        DESCOVY Gilead Sciences INC Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-37        / Salix Pharmaceuticals, Inc. Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-38        Rapamune PF PRISM CV Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-39        Rapamune PF PRISM CV Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-40        / Bausch and Lomb Pharmaceuticals Inc Internationally recognized to be equivalent to the original drug US Orange Book The 77th Batch of Reference Listed Drugs
77-41        / ALLERGAN SALES LLC Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-42        STALEVO Orion Pharma Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs